These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1052583)

  • 1. [Purity control of influenza virus vaccinal preparations obtained chromatographically].
    Potokin IL; Bresler SE; Katushkina NV; Kolikov VM; Vinogradskaia GR
    Tr Inst Im Pastera; 1976; 47():49-53. PubMed ID: 1052583
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obtaining concentrated influenza virus preparations by adsorption liquid chromatography].
    Polianskaia NIu; Oganova NIu
    Tr Inst Im Pastera; 1979; 52():99-103. PubMed ID: 550554
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of the chromatographic purification of influenza viruses on porous silicate sorbents].
    Molodkin VM; Mchedlishvili BV; Katushkina NV; Zheleznova NV; Polianskaia NIu
    Tr Inst Im Pastera; 1976; 47():34-8. PubMed ID: 210541
    [No Abstract]   [Full Text] [Related]  

  • 4. [Charcateristics of vaccinal preparations obtained by a combination of methods of adsorption, chromatography and ultrafiltration].
    Zheleznova NV; Fridman EA; Bichurina MA; Goriunova VV; Bokhnevich GM
    Tr Inst Im Pastera; 1979; 52():88-91. PubMed ID: 550551
    [No Abstract]   [Full Text] [Related]  

  • 5. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses.
    Opitz L; Salaklang J; Büttner H; Reichl U; Wolff MW
    Vaccine; 2007 Jan; 25(5):939-47. PubMed ID: 17011087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles.
    Opitz L; Lehmann S; Reichl U; Wolff MW
    Biotechnol Bioeng; 2009 Aug; 103(6):1144-54. PubMed ID: 19449393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns.
    Kalashnikova I; Ivanova N; Tennikova T
    Anal Chem; 2008 Mar; 80(6):2188-98. PubMed ID: 18271603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography.
    Opitz L; Hohlweg J; Reichl U; Wolff MW
    J Virol Methods; 2009 Nov; 161(2):312-6. PubMed ID: 19591872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selection of the influenza virus vaccinal strain by means of crossed protection experiments on mice].
    Briantseva EA
    Tr Inst Im Pastera; 1976; 47():19-23. PubMed ID: 1088724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Biological and physicochemical principles of producing killed influenza vaccines].
    Fridman EA; Kolikov VM; Peradze TV
    Tr Inst Im Pastera; 1976; 47():7-13. PubMed ID: 1052953
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the purification of influenza virus vaccine. Filtration of formalin-inactivated influenza virus with Sepharose 6B.
    Tomita S; Asahara T
    Kitasato Arch Exp Med; 1971 Dec; 44(3):185-96. PubMed ID: 5155555
    [No Abstract]   [Full Text] [Related]  

  • 13. [Control of killed influenza vaccine purified and concentrated on silicate sorbents].
    Medvedkova AA; Karpovich NM
    Tr Inst Im Pastera; 1976; 47():54-5. PubMed ID: 210542
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influenza A(H1N1) virus drift; alteration of the influenza vaccine for the 1986/'87 season].
    Masurel N; Beyer WE
    Ned Tijdschr Geneeskd; 1986 Oct; 130(43):1929-30. PubMed ID: 2430197
    [No Abstract]   [Full Text] [Related]  

  • 15. [The possibility of the circulation of vaccinal influenza A viral strains in the biosphere].
    Petrov NA; Kiselev OI; Grinbaum EB; Luzianina TIa; Polezhaev FI; Vasilenko SK
    Dokl Akad Nauk SSSR; 1990; 315(3):725-8. PubMed ID: 2097126
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthesis and properties of an affinity adsorbent for purifying neuraminidases of varying origins].
    Poltorak AN; Martiushin SV; Pasechnik VA
    Prikl Biokhim Mikrobiol; 1985; 21(3):365-71. PubMed ID: 2864684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of ELISA and radial immunodiffusion tests for evaluation of the degree of purification of influenza diagnostic and vaccine preparations].
    Paszkowska M; Jankowski M
    Med Dosw Mikrobiol; 1991; 43(3-4):135-43. PubMed ID: 1823376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influenza in the 1991/'92 season; vaccine combination for the 1992/'93 season].
    Masurel N
    Ned Tijdschr Geneeskd; 1992 Sep; 136(36):1780-3. PubMed ID: 1407129
    [No Abstract]   [Full Text] [Related]  

  • 19. [Method of influenza virus UV inactivation applied to the manufacture of an inactivated chromatographic influenza vaccine].
    Zheleznova NV
    Tr Inst Im Pastera; 1982; 59():81-8. PubMed ID: 7187573
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
    Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.